Approval · Notice of Compliance 10316 · 2009
CAMPRAL: Notice of Compliance 10316
Issued June 29, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10316
- Date
- June 29, 2009
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Alcohol Abstinence Aid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAMPRAL | 02293269 | Marketed |
Medicinal ingredients
- ACAMPROSATE CALCIUM 333 MG per TAB